Keith Jahans
Veterinary Laboratories Agency
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Keith Jahans.
Journal of Clinical Microbiology | 2006
Simeon Cadmus; Si Palmer; Melissa Okker; James Dale; Karen Gover; Noel H. Smith; Keith Jahans; R. Glyn Hewinson; Stephen V. Gordon
ABSTRACT To establish a molecular epidemiological baseline for the strains causing tuberculosis in Nigeria, a survey of isolates from humans and cattle was carried out. Spoligotyping and variable-number tandem-repeat analysis revealed that the majority of tuberculosis disease in humans in Ibadan, southwestern Nigeria, is caused by a single, closely related group of Mycobacterium tuberculosis strains. Using deletion typing, we show that approximately 13% of the disease in humans in this sample was caused by strains of Mycobacterium africanum and Mycobacterium bovis rather than M. tuberculosis. Molecular analysis of strains of M. bovis recovered from Nigerian cattle show that they form a group of closely related strains that show similarity to strains from neighboring Cameroon. Surprisingly, the strains of M. bovis recovered from humans do not match the molecular type of the cattle strains, and possible reasons for this are discussed. This is the first molecular analysis of M. tuberculosis complex strains circulating among humans and cattle in Nigeria, the results of which have significant implications for disease control.
Veterinary Immunology and Immunopathology | 2008
Shelley Rhodes; Tim Gruffydd-Jones; Danielle Gunn-Moore; Keith Jahans
There are currently no reliable immunodiagnostic tests for feline tuberculosis. Infection of domestic cats in the UK is thought to occur via their contact with the relevant reservoir of infection, e.g. cattle and badgers for Mycobacterium bovis, and rodents for M. microti. In the African National Parks, where M. bovis infection of Bovidae is an increasing problem, transmission to big cats is occurring via their ingestion of infected carcasses. We have adapted feline ELISA and ELISPOT assays to potentially provide the first cell-based diagnostic test for the detection of tuberculosis in cats. We tested peripheral blood mononuclear cell antigen-specific IFN-gamma responses of 18 cats suspected of mycobacterial infection for which biopsy material was co-submitted to the Veterinary Laboratories Agency for mycobacterial culture and identification. Seventeen cats were tested by ELISA while seven cats were tested by ELISPOT (six cats were tested by both ELISA and ELISPOT). Six healthy control cats provided baseline data for these tests. Responses to bovine and avian tuberculins (PPDB and PPDA) and a protein cocktail of ESAT6 and CFP10 were measured, together with positive mitogen (PMA and calcium ionophore) and negative (medium) controls. Overall, both ELISPOT and ELISA tests were found to be suitable for generating rapid results (2 and 4 days, respectively), which provided good predictive information for M. bovis and M. microti infections, but were unable to reliably discern M. avium infection.
Vaccine | 2003
Philip J. Hogarth; Keith Jahans; Rolf Hecker; R. Glyn Hewinson; Mark A. Chambers
Subunit vaccines against tuberculosis show promise but require administration with adjuvants to stimulate relevant immune responses for protection. Guinea pigs are the model of choice for evaluating protective immunity to aerogenic challenge with virulent mycobacteria, but few studies have been undertaken to identify suitable adjuvants for vaccine screening in this species. Here, we compare the efficacy of several adjuvants to induce T cell responses to culture filtrate protein in guinea pigs. We report that of several adjuvants tested, the most promising was CpG ODN formulated in an aqueous emulsion. This adjuvant induced type 1 T cell responses equivalent to that of FIA, as measured by delayed-type hypersensitivity reactions (DTH), antigen-specific T cell proliferation and antigen-specific IgG1 and IgG2 responses. These data demonstrate the potential for CpG motif based adjuvants for use in TB vaccine screening in guinea pigs, and other diseases where a type 1 T cell response is required.
Veterinary Record | 2006
M. D. Ellis; S. Davies; Irene A P McCandlish; R. J. Monies; Keith Jahans
to a degree determined by the level of exposure, the level of innate resistance, predominant immu-nological pathways, type of husbandry, population density, interactions with other susceptible species and type of habitat (Morris and others 1994). However, the ability to sustain the infection and transmit
Veterinary Record | 2008
Shelley Rhodes; Tj Gruffydd-Jones; Danielle Gunn-Moore; Keith Jahans
FELINE submissions to the tb Diagnostic Section of the Veterinary Laboratories Agency (vla) increased between 2005 (98 submission) and 2006 (135 submissions) ([defra 2006][1]). Of primary concern to the vla is the detection or exclusion of Mycobacterium bovis , the presence of which is now
Skin Research and Technology | 2002
Mark A. Chambers; Keith Jahans; Adam O. Whelan; Catherine Hughes; Robin Sayers; Alan Perkins; R. Glyn Hewinson
Background/aims: A number of subjective methods have been used to quantify the extent of the cutaneous delayed‐type hypersensitivity (DTH) reaction. However, because of their subjective nature, significant differences in measurements may be seen between individual observers or laboratories unless thorough training is given to each observer.
BMC Veterinary Research | 2007
G. Michael Taylor; Danny R Worth; Si Palmer; Keith Jahans; R. Glyn Hewinson
Veterinary Record | 2006
Clare Taylor; Keith Jahans; Si Palmer; Melissa Okker; Jemma Brown; Keith Steer
Veterinary Record | 2004
Keith Jahans; Si Palmer; Inwald J; Brown J; Abayakoon S
Tuberculosis | 2003
Jacqueline Inwald; Keith Jahans; R. Glyn Hewinson; Stephen V. Gordon